It will also help the team launch a new facility to accelerate the development of healthcare technologies.
Scientists, engineers and doctors are working alongside regulatory, legal and business experts on the project – called Proteus.
Since the project launched in 2013, the team has designed and created a range of chemical probes to detect the presence of diseases in the lungs.
The probes can rapidly and accurately diagnose bacterial infections, helping to ensure patients are given appropriate treatments.
The team have also devised cutting edge light sensing technologies, including a camera that can detect sources of light inside the body to enable doctors to track medical tools used in minimally invasive procedures.
£3.8 million has been awarded by the Engineering and Physical Sciences Research Council (EPSRC) to continue to support the research for the next five years. Proteus has been backed by EPSRC since it was launched in 2013.
The investment will enable researchers to further develop the technology for clinical use, develop new world-leading technology and accelerate commercial translation.
Proteus is led by the University in collaboration with the University of Bath and Heriot Watt University. Experts from Durham University are joining team for the next phase of the project.
The project will also be supported by 15 PhD students at Edinburgh and the partner universities.
This investment will allow us to push the technology into multiple new areas of application. It will also enable us to develop project sustainability and support staff development and independence. As part of the project, we are investing in a unique facility that will allow the rapid bench-to-bedside transfer of the project’s technology.
Professor Mark Bradley, Director of Proteus, School of Chemistry
Source: University of Edinburgh